Trials / Recruiting
RecruitingNCT05538806
TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study
TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study - TIGER Meso Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 198 (estimated)
- Sponsor
- NovoCure Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this post-authorisation medical device study is to obtain real life data on the use of Tumor Treating Fields (TTFields) in patients with pleural mesothelioma in routine clinical care. Patients with pleural mesothelioma and clinical indication for TTFields treatment will be enrolled in the study after signing Informed consent to use their data and process it centrally for research purposes. The clinical indication for TTFields is one of the inclusion criteria and is defined prior to inclusion by the treating physician.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TTFields | all patients will receive routine clinical care and TTFields |
Timeline
- Start date
- 2023-08-01
- Primary completion
- 2027-12-01
- Completion
- 2028-06-01
- First posted
- 2022-09-14
- Last updated
- 2025-08-22
Locations
23 sites across 3 countries: Germany, Italy, Netherlands
Source: ClinicalTrials.gov record NCT05538806. Inclusion in this directory is not an endorsement.